Erratum: Disseminated tuberculosis following reduced-intensity cord blood transplantation for adult patients with hematologic diseases (Bone Marrow Transplantation (2005) vol. 35 (91-97) 10.1038/sj.bmt.1704740);Disseminated tuberculosis following reduced-intensity cord blood transplantation for adult patients with hematological diseases

Bone Marrow Transplantation

Volumn 35, Issue 1, 2005, Pages 91-97

  Maeda, T ^a   Kusumi, E ^a   Kami, M ^b   Kawabata, M ^a   Le Pavoux, A ^a   Hara, S ^a   Chizuka, A ^b   Murashige, N ^b   Tanimoto, T E ^c   Matsumura, T ^a   Yuji, Ko ^a   Wake, A ^a   Miyakoshi, S ^a   Morinaga, S ^a   Taniguchi, S ^a  

^a TORANOMON HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Caseous necrosis; Miliary tuberculosis; Mycobacterium tuberculosis; Nonmyeloablative hematopoietic stem cell transplantation

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; COTRIMOXAZOLE; CYCLOSPORIN; ETHAMBUTOL; FLUCONAZOLE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; ISONIAZID; MELPHALAN; METHYLPREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN; TACROLIMUS; TOSUFLOXACIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BACTERIAL INFECTION; CHRONIC MYELOID LEUKEMIA; CORD BLOOD STEM CELL TRANSPLANTATION; DRUG EFFICACY; FEBRILE NEUTROPENIA; FEMALE; GRAFT VERSUS HOST REACTION; GRANULOMA; HEMATOLOGIC DISEASE; HERPES VIRUS INFECTION; HISTOLOGY; HUMAN; LIVER TOXICITY; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MILIARY TUBERCULOSIS; MULTIPLE ORGAN FAILURE; MYCOBACTERIOSIS; MYCOSIS; PLASMACYTOMA; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; T LYMPHOCYTE;

EID: 19944427617     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704824     Document Type: Erratum

References (31)

1. Goggins TF, Rizzieri DR. Nonmyeloablative allogeneic stem cell transplantation using alternative donors. Cancer Control 2004; 11: 86-96.
2. Rizzieri DA, Long GD, Vredenburgh JJ et al. Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen. Blood 2001; 98: 3486-3488.
3. Miyakoshi S, Yuji K, Kami M et al. Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases. Clin Cancer Res 2004; 10: 3586-3592.
4. Barker JN, Weisdorf DJ, DeFor TE et al. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003; 102: 1915-1919.
5. Rocha V, Wagner Jr JE, Sobocinski KA et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000; 342 1846-1854.
6. Saavedra S, Sanz GF, Jarque I et al. Early infections in adult patients undergoing unrelated donor cord blood transplantation. Bone Marrow Transplant 2002; 30: 937-943.
7. Tomonari A, Iseki T, Ooi J et al. Cytomegalovirus infection following unrelated cord blood transplantation for adult patients: a single institute experience in Japan. Br J Haematol 2003; 121: 304-311.
8. Tomonari A, Iseki T, Takahashi S et al. Varicella zoster virus infection in adult patients after unrelated cord blood transplantation: a single institute experience in Japan. Br J Haematol 2003; 122: 802-805.
9. Ohmori M, Ishikawa N, Yoshiyama T et al. Current epidemiological trend of tuberculosis in Japan. Int J Tuberc Lung Dis 2002; 6: 415-423.
10. Mori T. Current tuberculosis problem in Japan and its control. Intern Med 2002; 41: 56-57.
11. Aguado JM, Herrero JA, Gavalda J et al. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA. Transplantation 1997; 63: 1278-1286.
12. Selwyn PA, Hartel D, Lewis VA et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320: 545-550.
13. Navari RM, Sullivan KM, Springmeyer SC et al. Mycobacterial infections in marrow transplant patients. Transplantation 1983; 36: 509-513.
14. Kurzrock R, Zander A, Vellekoop L et al. Mycobacterial pulmonary infections after allogeneic bone marrow transplantation. Am J Med 1984; 77: 35-40.
15. Ip MS, Yuen KY, Chin EK et al. Pulmonary infections in bone marrow transplantation: the Hong Kong experience. Respiration 1995; 62: 80-83.
16. Ip MS, Yuen KY, Woo PC et al. Risk factors for pulmonary tuberculosis in bone marrow transplant recipients. Am J Respir Crit Care Med 1998; 158: 1173-1177.
17. Martino R, Martinez C, Brunet S et al. Tuberculosis in bone marrow transplant recipients: report of two cases and review of the literature. Bone Marrow Transplant 1996; 18: 809-812.
18. de la Camara R, Martino R, Granados E et al. Tuberculosis after hematopoietic stem cell transplantation: incidence, clinical characteristics and outcome. Spanish Group on Infectious Complications in Hematopoietic Transplantation. Bone Marrow Transplant 2000; 26: 291-298.
19. George B, Mathews V, Srivastava V et al. Tuberculosis among allogeneic bone marrow transplant recipients in India. Bone Marrow Transplant 2001; 27: 973-975.
20. Roy V, Weisdorf D. Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review. Bone Marrow Transplant 1997; 19: 467-470.
21. Ku SC, Tang JL, Hsueh PR et al. Pulmonary tuberculosis in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 1293-1297.
22. Przepiorka D, Weisdorf D, Martin P et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825-828.
23. Reusser P, Einsele H, Lee J et al. Randomized multicenter trial of foscarnet vs ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood 2002; 99: 1159-1164.
24. Rieder HL, Watson JM, Raviglione MC et al. Surveillance of tuberculosis in Europe. Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting on tuberculosis cases. Eur Respir J 1996; 9 (5): 1097-1104.
25. Tevere VJ, Hewitt PL, Dare A et al. Detection of Mycobacterium tuberculosis by PCR amplification with pan-Mycobacterium primers and hybridization to an M. tuberculosis-specific probe. J Clin Microbiol 1996; 34: 918-923.
26. Barnes PF, Bloch AB, Davidson PT, Snider Jr DE. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991; 324: 1644-1650.
27. Delaney V, Sumrani N, Hong JH, Sommer B. Mycobacterial infections in renal allograft recipients. Transplant Proc 1993; 25: 2288-2289.
28. Parkman R, Weinberg KI. Immunological reconstitution following bone marrow transplantation. Immunol Rev 1997; 157: 73-78.
29. Klein AK, Patel DD, Gooding ME et al. T-cell recovery in adults and children following umbilical cord blood transplantation. Biol Blood Marrow Transplant 2001; 7: 454-466.
30. Atkinson K. Reconstruction of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transplant 1990; 5: 209-226.
31. Singh N, Wagener MM, Gayowski T. Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis. Transplantation 2002; 74: 892-895.